Search by Drug Name or NDC

    NDC 70710-1759-06 Enoxaparin Sodium 60 mg/.6mL Details

    Enoxaparin Sodium 60 mg/.6mL

    Enoxaparin Sodium is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ENOXAPARIN SODIUM.

    Product Information

    NDC 70710-1759
    Product ID 70710-1759_55ef96d3-0a46-45ee-bb42-d2d23f76a80a
    Associated GPIs 8310102010E530
    GCN Sequence Number 027993
    GCN Sequence Number Description enoxaparin sodium SYRINGE 60MG/0.6ML SUBCUT
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 62771
    HICL Sequence Number 007878
    HICL Sequence Number Description ENOXAPARIN SODIUM
    Brand/Generic Generic
    Proprietary Name Enoxaparin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Enoxaparin Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 60
    Active Ingredient Units mg/.6mL
    Substance Name ENOXAPARIN SODIUM
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076726
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1759-06 (70710175906)

    NDC Package Code 70710-1759-6
    Billing NDC 70710175906
    Package 10 SYRINGE in 1 CARTON (70710-1759-6) / .6 mL in 1 SYRINGE (70710-1759-2)
    Marketing Start Date 2021-04-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 11.5339
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description ENOXAPARIN 60 MG/0.6 ML SYR
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis